The Latin America, Middle East and Africa Implantable Loop Recorders Market is expected to witness market growth of 12.9% CAGR during the forecast period (2020-2026).
Cardiovascular syncope, cardiac failure, stroke, and atrial fibrillation are two of the more important symptoms for which the usage of implantable loop recorders is anticipated to increase. Cardiovascular syncope and cardiac arrhythmias indication categories are estimated to reflect a significant market share and are predicted to continue a similar trend over the forecast period. The clinical usage of implantable loop recorders is on the increase because healthcare expenses are rising due to the growing amount of deaths due to heart-related problems.
A standardized, step-by-step treatment to patients with chronic syncope admitted to the emergency room has seen a substantial improvement in diagnostic output. Interestingly, these findings have found that invasive monitoring methods contribute nothing to the diagnosis. However, despite adequate clinical evaluation coupled with non-invasive monitoring, the definition of syncope can remain ambiguous in a substantial proportion of patients. By providing for continuous electrocardiographic monitoring, implantable loop recorders (ILRs) may have a more definite connection between the effects of the patient and recorded changes in the heart rhythm.
The ILR demand in developing countries is due largely to a rise in heart disease and an increase in the geriatric population. In addition, emerging applications across new fields of clinical research in medical devices are expected to open new avenues in the ILR market. The growth in government initiatives for health services in developing countries is also a significant driver of the ILR sector. Nevertheless, the cost of the product hampers the growth of the market.
Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technologies Ltd.
Scope of the Study
Market Segmentation:
By Application
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
Cardiovascular syncope, cardiac failure, stroke, and atrial fibrillation are two of the more important symptoms for which the usage of implantable loop recorders is anticipated to increase. Cardiovascular syncope and cardiac arrhythmias indication categories are estimated to reflect a significant market share and are predicted to continue a similar trend over the forecast period. The clinical usage of implantable loop recorders is on the increase because healthcare expenses are rising due to the growing amount of deaths due to heart-related problems.
A standardized, step-by-step treatment to patients with chronic syncope admitted to the emergency room has seen a substantial improvement in diagnostic output. Interestingly, these findings have found that invasive monitoring methods contribute nothing to the diagnosis. However, despite adequate clinical evaluation coupled with non-invasive monitoring, the definition of syncope can remain ambiguous in a substantial proportion of patients. By providing for continuous electrocardiographic monitoring, implantable loop recorders (ILRs) may have a more definite connection between the effects of the patient and recorded changes in the heart rhythm.
The ILR demand in developing countries is due largely to a rise in heart disease and an increase in the geriatric population. In addition, emerging applications across new fields of clinical research in medical devices are expected to open new avenues in the ILR market. The growth in government initiatives for health services in developing countries is also a significant driver of the ILR sector. Nevertheless, the cost of the product hampers the growth of the market.
Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technologies Ltd.
Scope of the Study
Market Segmentation:
By Application
- Atrial fibrillation
- Cardiac Arrhythmia and
- Cardiac syncope
By End User
- Hospitals
- Cardiac Centers
- Other End Users
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Angel Medical Systems, Inc.
- Vectorious Medical Technologies Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Implantable Loop Recorders Market by Application
Chapter 4. LAMEA Implantable Loop Recorders Market by End-user
Chapter 5. LAMEA Implantable Loop Recorders Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Angel Medical Systems, Inc.
- Vectorious Medical Technologies Ltd.
Methodology
LOADING...
